又一家！000638，或触及退市！

Core Viewpoint - *ST WanFang (000638) is at risk of financial delisting due to projected revenue below 300 million yuan and negative net profits for 2025 [1][4] Financial Performance - The company expects a revenue of less than 300 million yuan for 2025, with both pre-tax and post-tax net profits projected to be negative [1] - In 2024, the total profit was 6.4225 million yuan, with a net profit attributable to shareholders of 10.6516 million yuan, and a net profit after deducting non-recurring gains and losses of -4.6013 million yuan [6] - The operating revenue for 2024 was 391.4703 million yuan, with a net operating revenue of 227.5138 million yuan after deductions [6] Audit and Compliance Issues - The company received a qualified audit report from Zhongxing Caiguanghua Accounting Firm for the 2024 financial statements, indicating uncertainty regarding the recoverability of investments in Jilin WanFang Bai'ao Biotechnology Co., Ltd [4] - There is a risk of receiving a qualified audit report for the 2025 financial statements due to unresolved uncertainties [4] - The company faces potential forced delisting due to major legal violations, as it received a notice from the China Securities Regulatory Commission (CSRC) regarding suspected information disclosure violations [4] Business Overview - *ST WanFang primarily operates in agriculture and military industries, utilizing local agricultural resources to acquire and process corn and rice, and providing precision machining and special welding services for the aerospace, naval, and military sectors [5]